Rahayu Tri, Friska Dewi, Sopamena Yoslien, Menaldi Sri Linuwih, Gibran Kahlil, Ruwaida Ida, Irawati Yunia
Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Department of Community Medicine, Faculty of Medicine, Universitas Indonesia-Dr. Cipto Mangunkusumo, Jakarta, Indonesia.
Front Public Health. 2025 Jan 8;12:1474745. doi: 10.3389/fpubh.2024.1474745. eCollection 2024.
The Stigma Assessment and Reduction of Impact (SARI) Stigma Scale is an instrument developed to evaluate stigma in Leprosy patients. Despite existing versions in Indonesian, the absence of an endemic area language version of a reliable assessment tool presents a barrier to effective interventions in regions like Ambon. This study aims to evaluate the validity and reliability of the Ambonese-Malay Language of SARI Stigma Scale questionnaire.
A cross-sectional study involved 50 participants with leprosy or a history of leprosy from Ambon City, Indonesia. They were tested with the SARI Stigma Scale questionnaire, consisting of 4 domains of questions, totalling 21 questions. Reliability and variability analysis was conducted from each domain's questions. Cronbach's α (CA) and intraclass correlation coefficient (ICC) determined internal consistency of reliability tests. For validity assessment, coefficients of corrected item-total correlation ensured scale accuracy for measuring stigma.
Reliability analysis revealed significant high internal consistency (α and ICC value >0.7) across all four domains, with CA values ranging from 0.71 to 0.94 and strong consistency among responses, with ICC ranging from 0.71 to 0.94 across domains. The total domain exhibited a CA of 0.855 and an average ICC of 0.855 ( < 0.001). Validity testing demonstrated significant moderate to strong correlations, ranging from 0.69 to 0.90 (p < 0.001), affirming scale validity in measuring stigma accurately.
The Ambonese-Malay version of the SARI Stigma Scale exhibits validity and reliability as an assessment tool for scoring stigma in leprosy patients in Ambon. Stigma can emerge and be associated with leprosy. To understand the stigma in society due to this disease, a validated questionnaire in the local language and adjusted with the local cultures needed.
耻辱感评估与影响降低(SARI)耻辱感量表是一种用于评估麻风病患者耻辱感的工具。尽管已有印尼语版本,但缺乏可靠评估工具的地方语言版本,这对安汶等地区的有效干预造成了障碍。本研究旨在评估SARI耻辱感量表问卷安汶马来语版本的有效性和可靠性。
一项横断面研究纳入了50名来自印度尼西亚安汶市的麻风病患者或有麻风病史的参与者。他们接受了SARI耻辱感量表问卷测试,该问卷由4个问题领域组成,共21个问题。对每个领域的问题进行了可靠性和变异性分析。通过克朗巴哈α系数(CA)和组内相关系数(ICC)确定可靠性测试的内部一致性。为了进行有效性评估,校正后的项目-总分相关系数确保了量表在测量耻辱感方面的准确性。
可靠性分析显示,所有四个领域的内部一致性均显著较高(α和ICC值>0.7),CA值范围为0.71至0.94,各领域之间的回答一致性很强,ICC范围为0.71至0.94。总领域的CA为0.855,平均ICC为0.855(<0.001)。有效性测试显示,相关性显著中等至强,范围为0.69至0.90(p<0.001),确认了量表在准确测量耻辱感方面的有效性。
SARI耻辱感量表的安汶马来语版本作为安汶麻风病患者耻辱感评分的评估工具,具有有效性和可靠性。耻辱感可能会出现并与麻风病相关。为了了解社会因这种疾病而产生的耻辱感,需要一份经过验证的当地语言问卷,并根据当地文化进行调整。